Crinetics Pharmaceuticals (CRNX)
(Delayed Data from NSDQ)
$43.32 USD
-0.90 (-2.04%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $43.30 -0.02 (-0.05%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/2/24 |
---|---|
Current Quarter | -0.84 |
EPS Last Quarter | -0.90 |
Last EPS Surprise | -1.12% |
ABR | 1.15 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -3.34 |
Next Year | -3.55 |
EPS (TTM) | -3.70 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.82M | 2.20M | 3.83M | 32.11M |
# of Estimates | 2 | 3 | 3 | 7 |
High Estimate | 1.00M | 5.00M | 5.00M | 94.69M |
Low Estimate | 0.63M | 0.60M | 2.48M | 3.00M |
Year ago Sales | 2.68M | 0.99M | 4.01M | 3.83M |
Year over Year Growth Est. | -69.59% | 122.22% | -4.54% | 738.06% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.84 | -0.83 | -3.34 | -3.55 |
# of Estimates | 7 | 7 | 8 | 7 |
Most Recent Consensus | -0.72 | -0.70 | -2.97 | -3.95 |
High Estimate | -0.68 | -0.70 | -2.90 | -2.77 |
Low Estimate | -0.94 | -0.95 | -3.83 | -4.86 |
Year ago EPS | -0.85 | -0.94 | -3.69 | -3.34 |
Year over Year Growth Est. | 1.18% | 11.70% | 9.49% | -6.32% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 4 | 5 | 6 | 5 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 2 | 2 | 2 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.84 | -0.83 | -3.34 | -3.55 |
7 Days Ago | -0.84 | -0.83 | -3.34 | -3.55 |
30 Days Ago | -0.84 | -0.83 | -3.34 | -3.55 |
60 Days Ago | -0.89 | -0.73 | -3.50 | -3.73 |
90 Days Ago | -0.89 | -0.73 | -3.50 | -3.73 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.84 | -0.83 | -3.34 | -3.55 |
Zacks Consensus Estimate | -0.84 | -0.83 | -3.34 | -3.55 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.90 | -1.01 | -0.94 | -0.85 | NA |
Estimate | -0.89 | -0.89 | -0.85 | -0.82 | NA |
Difference | -0.01 | -0.12 | -0.09 | -0.03 | -0.06 |
Surprise | -1.12% | -13.48% | -10.59% | -3.66% | -7.21% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more